ipsen uk
The UK & Ireland together form one of three global hubs for Ipsen, encompassing
the entire value chain of medicines discovery, development, manufacturing and
commercialisation.Ipsen was first established as a business in the UK in 1981,
and in Ireland in 1989. Today, the UK & Ireland forms a critical and growing
part of our Global network and is one of our core operating hubs alongside
Cambridge, M.A., USA and Paris, France. As a UK & Ireland Hub we are
collaborating to deliver outcomes for patients, health services and our
community of current and future colleagues. Three of Ipsen’s leading medicines
are manufactured in the UK & Ireland, with our UK footprint also ‘home’ to the
global neuroscience franchise, with neurotoxin research, development, and
manufacturing capabilities located across our Milton Park (Oxford) and Wrexham
facilities.